awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36625210-2EBE329A-FD0C-4064-A410-3E170E52BC28
Q36625210-2EBE329A-FD0C-4064-A410-3E170E52BC28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36625210-2EBE329A-FD0C-4064-A410-3E170E52BC28
Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502.
P304
Q36625210-2EBE329A-FD0C-4064-A410-3E170E52BC28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36625210-2EBE329A-FD0C-4064-A410-3E170E52BC28
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a430b3bfac63ba0dbd09abba30788553360b7db3
P304
923-929
http://www.w3.org/2001/XMLSchema#string